Pacific maintains Xiangsheng Medical's buy rating: Ultrasound revenue maintains a stable growth rate of 20% throughout the year, and 22Q1 revenue increases by 23%.

  • Post date April 19, 2022 — 18:11 Post Lock Login to View

Key Data Concepts:   
? These are the company names, stock quotes, topics, and entities related to this data.

Chison Healthcare Technologies Strategy, Marketing Research, Development Construction, Property Paper, Packaging Product Market, Exchange Epidemic Economy, Business, Finance

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets


Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!


Already have an account?
Login



Related Data